Cargando…
Recovery From COVID-19 in Multiple Sclerosis: A Prospective and Longitudinal Cohort Study of the United Kingdom Multiple Sclerosis Register
BACKGROUND AND OBJECTIVES: To understand the course of recovery from coronavirus disease 2019 (COVID-19) among patients with multiple sclerosis (MS) and to determine its predictors, including patients' pre–COVID-19 physical and mental health status. METHODS: This prospective and longitudinal co...
Autores principales: | Garjani, Afagh, Middleton, Rodden M., Nicholas, Richard, Evangelou, Nikos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631790/ https://www.ncbi.nlm.nih.gov/pubmed/34848503 http://dx.doi.org/10.1212/NXI.0000000000001118 |
Ejemplares similares
-
Self-diagnosed COVID-19 in people with multiple sclerosis: a community-based cohort of the UK MS Register
por: Evangelou, Nikos, et al.
Publicado: (2021) -
COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies
por: Garjani, Afagh, et al.
Publicado: (2021) -
An update on the use of sphingosine 1-phosphate receptor modulators for the treatment of relapsing multiple sclerosis
por: Dumitrescu, Laura, et al.
Publicado: (2023) -
Decentralised clinical trials in multiple sclerosis
research
por: Garjani, Afagh, et al.
Publicado: (2022) -
Impact of mass vaccination on SARS-CoV-2 infections among multiple sclerosis patients taking immunomodulatory disease-modifying therapies in England
por: Garjani, Afagh, et al.
Publicado: (2022)